Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
CEO: Mikhael Nassif. Company website
Neogen Corporation (NEOG) trades at $13.00, up 1.33% on the day, as of Sep 20, 2026 15:01 UTC.
Neogen Corporation has a market capitalisation of $2.83B, calculated from the live NEOG share price and shares outstanding.
NEOG has no meaningful price-to-earnings ratio: Neogen Corporation lost $0.03 per share over the last twelve months, and a P/E is only defined on positive earnings.
Neogen Corporation generated revenue of $870.38M over the trailing twelve months, which puts the stock at 3.26 times sales.
NEOG has traded between $4.90 and $13.07 over the past 52 weeks, and the last price is 0.5% below that high.
No. Neogen Corporation is loss-making, with a net margin of -0.91% over the trailing twelve months.
Wall Street analysts rate NEOG Buy, with an average price target of $13.00, 0.0% above the current price.
Neogen Corporation is classified under the Healthcare sector and the Medical - Devices industry, and is domiciled in US.
Mikhael Nassif is the chief executive of Neogen Corporation, which employs 2,636 people.
QFI Terminal shows NEOG with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open NEOG in Terminal See plans